Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful? (Q33538461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

D F Hayes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B Trock

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

305-319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10066089%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006197805041

11 November 2019

exact match

0 references

cites work

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

7 January 2021

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

7 January 2021

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

7 January 2021

Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

7 January 2021

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006197805041

7 January 2021